Gouvernance Cogstate Limited

Actions

CGS

AU000000CGS8

Recherche biotechnologique et médicale

Marché Fermé - Australian S.E. 08:10:05 22/07/2026 Varia. 5j. Varia. 1 janv.
2,630 AUD -2,95% Graphique intraday de Cogstate Limited -4,71% +16,37%

Comité Exécutif: Cogstate Limited

Dirigeant
Fonctions occupéesDepuis
Bradley O'Connor

Bradley O'Connor

Chief Executive Officer 01/12/2005
Investor Relations Contact 01/05/2004
Darren Watson

Darren Watson

Director of Finance/CFO 01/02/2021
Corporate Secretary 22/05/2026
David Franks

David Franks

55 ans

Corporate Secretary 26/02/2021
Sara Giesen

Sara Giesen

Human Resources Officer -
Pamela Ventola

Pamela Ventola

Chief Tech/Sci/R&D Officer 01/01/2024
Kaycee Sink

Kaycee Sink

Chief Tech/Sci/R&D Officer 14/10/2024

Composition du Conseil d'Administration: Cogstate Limited

Administrateur
ComitésDepuis
Martyn Myer

Martyn Myer

67 ans

Compensation Committee Chair 03/11/2009
Nominating Committee Chair 03/11/2009
Ingrid Player

Ingrid Player

52 ans

Compensation Committee 29/08/2023
Nominating Committee 29/08/2019
Audit Committee Chair 21/10/2019
HR Committee 29/08/2023
Audit Committee 29/08/2023
Kim Wenn

Kim Wenn

Audit Committee 30/11/2020
Nominating Committee 30/11/2020
Compensation Committee Chair 01/01/2026
Darryl Inns

Darryl Inns

Audit Committee 01/05/2026
Nominating Committee 01/05/2026
Richard Mohs

Richard Mohs

Compensation Committee 20/01/2017
Nominating Committee 20/01/2017
Bradley O'Connor

Bradley O'Connor

Director/Board Member 01/03/2011

Anciens Dirigeants et Administrateurs: Cogstate Limited

Insider
Fonctions occupées
DepuisJusqu'au
Kristi Geddes
Kristi Geddes
General Counsel 27/04/2023 22/05/2026
Corporate Secretary - 22/05/2026
Richard van den Broek
Richard van den Broek
Director/Board Member 01/01/2009 21/05/2025
Independent Dir/Board Member 01/01/2009 21/05/2025
Kate Jopling
Kate Jopling
Chief Operating Officer 01/01/2014 01/03/2024
Chris Edgar
Chris Edgar
Chief Tech/Sci/R&D Officer 01/10/2020 29/02/2024
Corporate Officer/Principal 10/02/2018 01/10/2020
Kenneth Billard
Kenneth Billard
Corporate Officer/Principal 19/11/2019 01/06/2023
David Dolby
David Dolby
Director/Board Member 23/11/2013 25/01/2023
Independent Dir/Board Member 23/11/2013 25/01/2023
Benjamin Bloomfield
Benjamin Bloomfield
Chief Tech/Sci/R&D Officer 11/01/2021 01/01/2023
Tanya O'Connor
Tanya O'Connor
Corporate Officer/Principal 01/09/2019 01/09/2022
Keith Hawkins
Keith Hawkins
Corporate Secretary 20/12/2019 26/02/2021
John Glueck
John Glueck
General Counsel 01/02/2020 26/06/2020
Corporate Secretary 26/06/2020 26/02/2021
Richard Gleeson
Richard Gleeson
Chief Tech/Sci/R&D Officer - 01/01/2020
Claire Newstead-Sinclair
Claire Newstead-Sinclair
Director of Finance/CFO - 20/12/2019
Human Resources Officer - 20/12/2019
General Counsel - 20/12/2019
Corporate Secretary 01/01/2010 20/12/2019
Jane McAloon
Jane McAloon
Director/Board Member 01/01/2017 21/10/2019
Independent Dir/Board Member 01/01/2017 21/10/2019
Lammert Albers
Lammert Albers
Sales & Marketing - 01/10/2019
Frank J. Cheng
Frank J. Cheng
Corporate Officer/Principal 24/11/2016 31/12/2018
George Hunnewell
George Hunnewell
Chief Operating Officer 24/11/2016 01/05/2018
David Simpson
David Simpson
Director/Board Member 03/11/2009 25/10/2017
Independent Dir/Board Member - 25/10/2017
Abby Moore
Abby Moore
Corporate Secretary - 31/08/2016
Cindy Tilley
Cindy Tilley
Director of Finance/CFO 30/08/2016 -
Corporate Secretary 30/08/2016 -
Alan Finkel
Alan Finkel
Director/Board Member 12/05/2015 -
Sophie Egholm
Sophie Egholm
Chief Operating Officer - 10/10/2013
Chief Tech/Sci/R&D Officer 10/10/2013 13/03/2015
Rodolfo Chapa
Rodolfo Chapa
Director/Board Member 26/08/2011 15/09/2014
Independent Dir/Board Member 24/08/2011 15/09/2014
Craig Gravina
Craig Gravina
Chief Tech/Sci/R&D Officer 02/06/2014 -
Mark Edwards
Mark Edwards
Corporate Secretary 01/05/2013 -
Dale Fraser
Dale Fraser
Chief Tech/Sci/R&D Officer 03/11/2009 15/03/2013
Brendan Owen
Brendan Owen
Chief Tech/Sci/R&D Officer 01/01/2020 -
John Harrison
John Harrison
Chief Tech/Sci/R&D Officer 01/03/2011 31/08/2011
David Gordon Darby
David Gordon Darby
Chief Tech/Sci/R&D Officer 04/11/2009 01/07/2011
Founder 02/03/2011 01/07/2011
Corporate Officer/Principal 03/11/2009 04/11/2009
Richard Morgan
Richard Morgan
Director/Board Member 03/11/2009 30/06/2011
Michael R. L. Wooldridge
Michael R. L. Wooldridge
Director/Board Member 03/11/2009 30/06/2011
Independent Dir/Board Member 25/04/2011 30/06/2011
Lauren Delaney
Lauren Delaney
Corporate Secretary 09/11/2009 30/08/2010
Anthony Panther
Anthony Panther
Director of Finance/CFO 03/11/2009 09/11/2009
Corporate Secretary 03/11/2009 09/11/2009
Geoff Brooke
Geoff Brooke
Director/Board Member - 25/10/2007
Ben Gust
Ben Gust
Corporate Secretary 01/05/2006 -
Lauren Hastie
Lauren Hastie
Director of Finance/CFO 30/04/2007 -
Mala Bisunadan
Mala Bisunadan
General Counsel 01/01/2006 -
Meadows Bruce
Meadows Bruce
Director/Board Member 01/12/1999 01/02/2004
Tanya Chenhall
Tanya Chenhall
Chief Tech/Sci/R&D Officer - -
Roger O'Sullivan
Roger O'Sullivan
General Counsel - -
Corporate Secretary - -

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme9
Femme4

Dont comité exécutif

Homme5
Femme1

Dont Administrateurs

Homme4
Femme2
Logo Cogstate Limited
Cogstate Limited est une société de technologie neuroscientifique qui optimise les évaluations de la santé cérébrale afin de faire progresser le développement de nouveaux médicaments et de permettre des analyses cliniques plus rapides dans le domaine des soins de santé. Ses principales activités sont la création, la validation et la commercialisation d'évaluations numériques de la santé du cerveau, ainsi que la conception et la fourniture de services d'assurance qualité dans le cadre d'essais cliniques, axés sur l'administration, la notation et l'enregistrement d'évaluations conventionnelles de la santé du cerveau. Ses secteurs d'activité sont les essais cliniques, les soins de santé et l'administration. Dans le secteur des essais cliniques, la technologie et les services associés sont utilisés pour quantifier l'effet de la maladie et des médicaments, dispositifs ou autres interventions sur des sujets humains participant à des essais cliniques principalement menés par des sociétés pharmaceutiques et biotechnologiques. Dans le secteur des soins de santé, la technologie et les services associés sont développés en tant qu'outil permettant aux médecins de premier recours et/ou aux hôpitaux d'évaluer le déclin cognitif.
Employés
160